Role of the endocannabinoid system in metabolic control

Isolation and Structure of a Brain Constituent That Binds to the Cannabinoid Receptor

Devane, W. A., Hanuš, L., Breuer, A., Pertwee, R. G., Stevenson, L. A., Griffin, G., Gibson, D., Mandelbaum, A., Etinger, A., & Mechoulam, R. (1992) · Science · doi:10.1126/science.1470919 · Cited by 5,633 · see citing works

Molecular characterization of a peripheral receptor for cannabinoids

Munro, S., Thomas, K. L., & Abu-Shaar, M. (1993) · Nature · doi:10.1038/365061a0 · Cited by 5,092 · see citing works

Structure of a cannabinoid receptor and functional expression of the cloned cDNA

Matsuda, L. A., Lolait, S. J., Brownstein, M. J., Young, A. C., & Bonner, T. I. (1990) · Nature · doi:10.1038/346561a0 · Cited by 5,011 · see citing works

Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors

Mechoulam, R., Ben-Shabat, S., Hanus, L., Ligumsky, M., Kaminski, N. E., Schatz, A. R., Gopher, A., Almog, S., Martin, B. R., Compton, D. R., et al. (1995) · Biochemical Pharmacology · doi:10.1016/0006-2952(95)00109-d · Cited by 2,913 · see citing works

Isolation, Structure, and Partial Synthesis of an Active Constituent of Hashish

Gaoni, Y., & Mechoulam, R. (1964) · Journal of the American Chemical Society · doi:10.1021/ja01062a046 · Cited by 2,389 · see citing works

2-Arachidonoylgylcerol: A Possible Endogenous Cannabinoid Receptor Ligand in Brain

Sugiura, T., Kondo, S., Sukagawa, A., Nakane, S., Shinoda, A., Itoh, K., Yamashita, A., & Waku, K. (1995) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1995.2437 · Cited by 2,196 · see citing works

The Endocannabinoid System as an Emerging Target of Pharmacotherapy

Pacher, P., Bátkai, S., & Kunos, G. (2006) · Pharmacological Reviews · doi:10.1124/pr.58.3.2 · Cited by 2,077 · see citing works

The molecular logic of endocannabinoid signalling

Piomelli, D. (2003) · Nature Reviews Neuroscience · doi:10.1038/nrn1247 · Cited by 1,957 · see citing works

Leptin-regulated endocannabinoids are involved in maintaining food intake

Di Marzo, V., Goparaju, S. K., Wang, L., Liu, J., Bátkai, S., Járai, Z., Fezza, F., Miura, G. I., Palmiter, R. D., Sugiura, T., et al. (2001) · Nature · doi:10.1038/35071088 · Cited by 1,559 · see citing works

Effects of the cannabinoid-1 receptor blocker rimonabant on weight reduction and cardiovascular risk factors in overweight patients: 1-year experience from the RIO-Europe study

Gaal, L. F. V., Rissanen, A., Scheen, A. J., Ziegler, O., & Rössner, S. (2005) · The Lancet · doi:10.1016/s0140-6736(05)66374-x · Cited by 1,500 · see citing works

Identification and Functional Characterization of Brainstem Cannabinoid CB₂Receptors

Van Sickle, M. D., Duncan, M., Kingsley, P. J., Mouihate, A., Urbani, P., Mackie, K., Stella, N., Makriyannis, A., Piomelli, D., Davison, J. S., et al. (2005) · Science · doi:10.1126/science.1115740 · Cited by 1,470 · see citing works

Effects of rimonabant on metabolic risk factors in overweight patients with dyslipidemia

Després, J.-P., Golay, A., & Sjöström, L. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa044537 · Cited by 1,392 · see citing works

Physiological role of adipose tissue: white adipose tissue as an endocrine and secretory organ

Trayhurn, P., & Beattie, J. H. (2001) · Proceedings of The Nutrition Society · doi:10.1079/pns200194 · Cited by 1,259 · see citing works

Effect of Rimonabant, a Cannabinoid-1 Receptor Blocker, on Weight and Cardiometabolic Risk Factors in Overweight or Obese Patients

Pi-Sunyer, X., Aronne, L. J., Heshmati, H. M., Devin, J., Rosenstock, J., & for the RIO-North America Study Group (2006) · JAMA · doi:10.1001/jama.295.7.761 · Cited by 1,209 · see citing works

The endogenous cannabinoid system affects energy balance via central orexigenic drive and peripheral lipogenesis

Cota, D., Marsicano, G., Tschöp, M. H., Grübler, Y., Flachskamm, C., Schubert, M. I., Auer, D. P., Yassouridis, A., Thöne‐Reineke, C., Ortmann, S., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci17725 · Cited by 1,168 · see citing works

Oleylethanolamide regulates feeding and body weight through activation of the nuclear receptor PPAR-α

Fu, J., Gaetani, S., Oveisi, F., Verme, J., Serrano, A., de Fonseca, F. D., Rosengarth, A., Luecke, H., Giacomo, B. D., Tarzia, G., et al. (2003) · Nature · doi:10.1038/nature01921 · Cited by 1,113 · see citing works

Endocannabinoid activation at hepatic CB1 receptors stimulates fatty acid synthesis and contributes to diet-induced obesity

Osei‐Hyiaman, D., DePetrillo, M. A., Pacher, P., Liu, J., Radaeva, S., Bátkai, S., Harvey-White, J. D., Mackie, K., Offertáler, L., Wang, L., et al. (2005) · Journal of Clinical Investigation · doi:10.1172/jci23057 · Cited by 1,103 · see citing works

The endocannabinoid system and its therapeutic exploitation

Marzo, V. D., Bifulco, M., & Petrocellis, L. D. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1495 · Cited by 1,090 · see citing works

Cloning of the first sn1-DAG lipases points to the spatial and temporal regulation of endocannabinoid signaling in the brain

Bisogno, T., Howell, F., Williams, G., Minassi, A., Cascio, M. G., Ligresti, A., Matias, I., Schiano-Moriello, A., Paul, P., Williams, E.-J., et al. (2003) · The Journal of Cell Biology · doi:10.1083/jcb.200305129 · Cited by 1,039 · see citing works

The Emerging Role of the Endocannabinoid System in Endocrine Regulation and Energy Balance

Pagotto, U., Marsicano, G., Cota, D., Lutz, B., & Pasquali, R. (2005) · Endocrine Reviews · doi:10.1210/er.2005-0009 · Cited by 856 · see citing works

Cannabinoid CB2 receptors: immunohistochemical localization in rat brain

Gong, J.-P., Onaivi, E. S., Ishiguro, H., Liu, Q.-R., Tagliaferro, P. A., Brusco, A., & Uhl, G. R. (2006) · Brain Research · doi:10.1016/j.brainres.2005.11.035 · Cited by 820 · see citing works

Molecular Characterization of a Phospholipase D Generating Anandamide and Its Congeners

Okamoto, Y., Morishita, J., Tsuboi, K., Tonai, T., & Ueda, N. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m306642200 · Cited by 800 · see citing works

Endocannabinoid levels in rat limbic forebrain and hypothalamus in relation to fasting, feeding and satiation: stimulation of eating by 2-arachidonoyl glycerol

Kirkham, T. C., Williams, C. M., Fezza, F., & Marzo, V. D. (2002) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704767 · Cited by 788 · see citing works

Efficacy and tolerability of rimonabant in overweight or obese patients with type 2 diabetes: a randomised controlled study

Scheen, A. J., Finer, N., Hollander, P. A., Jensen, M. D., & Gaal, L. F. V. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69571-8 · Cited by 729 · see citing works

An anorexic lipid mediator regulated by feeding

de Fonseca, F. R., Navarro, M. A., de Heras, R. G., Escuredo, L., Nava, F. A., Fu, J., Murillo‐Rodríguez, E., Giuffrida, A., LoVerme, J., Gaetani, S., et al. (2001) · Nature · doi:10.1038/35102582 · Cited by 695 · see citing works

Activation of the peripheral endocannabinoid system in human obesity

Engeli, S., Böhnke, J., Feldpausch, M., Gorzelniak, K., Janke, J., Bátkai, S., Pacher, P., Harvey-White, J., Luft, F. C., Sharma, A. M., et al. (2005) · Diabetes · doi:10.2337/diabetes.54.10.2838 · Cited by 686 · see citing works

Structure and function of fatty acid amide hydrolase

McKinney, M. K., & Cravatt, B. F. (2005) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.74.082803.133450 · Cited by 680 · see citing works

Deorphanization of a G protein-coupled receptor for oleoylethanolamide and its use in the discovery of small-molecule hypophagic agents

Overton, H. A., Babbs, A. J., Doel, S. M., Fyfe, M. C. T., Gardner, L. S., Griffin, G., Jackson, H. C., Procter, M. J., Rasamison, C. M., Tang‐Christensen, M., et al. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.02.004 · Cited by 656 · see citing works

Regulation, Function, and Dysregulation of Endocannabinoids in Models of Adipose and β-Pancreatic Cells and in Obesity and Hyperglycemia

Matias, I., Gonthier, M., Orlando, P., Martiadis, V., PETROCELLIS, L. D., Cervino, C., Petrosino, S., Hoareau, L., Festy, F., Pasquali, R., et al. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-2679 · Cited by 654 · see citing works

The Cannabinoid CB1 Receptor Antagonist SR141716 Increases Acrp30 mRNA Expression in Adipose Tissue of Obese fa/fa Rats and in Cultured Adipocyte Cells

Bensaïd, M., Gary‐Bobo, M., Esclangon, A., Maffrand, J., Fur, G. L., Oury-Donat, F., & Soubrié, P. (2003) · Molecular Pharmacology · doi:10.1124/mol.63.4.908 · Cited by 593 · see citing works

CB1 cannabinoid receptor antagonism: a new strategy for the treatment of liver fibrosis

Teixeira-Clerc, F., Julien, B., Grenard, P., Nhieu, J. T. V., Deveaux, V., Li, L., Serrière-Lanneau, V., Ledent, C. A., Mallat, A., & Lotersztajn, S. (2006) · Nature Medicine · doi:10.1038/nm1421 · Cited by 527 · see citing works

Dysregulation of the Peripheral and Adipose Tissue Endocannabinoid System in Human Abdominal Obesity

Blüher, M., Engeli, S., Klöting, N., Berndt, J., Faßhauer, M., Bátkai, S., Pacher, P., Schön, M. R., Jordan, J., & Stümvoll, M. (2006) · Diabetes · doi:10.2337/db06-0812 · Cited by 526 · see citing works

A Peripheral Mechanism for CB1 Cannabinoid Receptor-Dependent Modulation of Feeding

Gómez, R., Navarro, M., Ferrer, B., Trigo, J. M., Bilbao, A., del Arco, I., Cippitelli, A., Nava, F. A., Piomelli, D., & de Fonseca, F. R. (2002) · Journal of Neuroscience · doi:10.1523/jneurosci.22-21-09612.2002 · Cited by 486 · see citing works

A biosynthetic pathway for anandamide

Liu, J., Wang, L., Harvey-White, J. D., Osei‐Hyiaman, D., Razdan, R. J., Gong, Q., Chan, A. C., Zhou, Z., Huang, B. X., Kim, H., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0601832103 · Cited by 468 · see citing works

Cannabinoid Receptor Signaling

Howlett, A. C. (2005) · Springer eBooks · doi:10.1007/3-540-26573-2_2 · Cited by 451 · see citing works

Allosteric Modulation of the Cannabinoid CB1 Receptor

Price, M. R., Baillie, G. L., Thomas, A., Stevenson, L. A., Easson, M., Goodwin, R., Mclean, A., McIntosh, L., Goodwin, G., Walker, G., et al. (2005) · Molecular Pharmacology · doi:10.1124/mol.105.016162 · Cited by 418 · see citing works

Evidence for novel cannabinoid receptors

Begg, M., Pacher, P., Bátkai, S., Osei‐Hyiaman, D., Offertáler, L., Mo, F.-M., LIU, J., & Kunos, G. (2005) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2004.11.005 · Cited by 385 · see citing works

Subcellular Arrangement of Molecules for 2-Arachidonoyl-Glycerol-Mediated Retrograde Signaling and Its Physiological Contribution to Synaptic Modulation in the Striatum

Uchigashima, M., Narushima, M., Fukaya, M., Katona, I., Kano, M., & Watanabe, M. (2007) · Journal of Neuroscience · doi:10.1523/jneurosci.0448-07.2007 · Cited by 375 · see citing works

A Second Fatty Acid Amide Hydrolase with Variable Distribution among Placental Mammals

Wei, B. Q., Mikkelsen, T. S., McKinney, M. K., Lander, E. S., & Cravatt, B. F. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m606646200 · Cited by 361 · see citing works

Biochemistry, pharmacology and physiology of 2-arachidonoylglycerol, an endogenous cannabinoid receptor ligand

SUGIURA, T., KISHIMOTO, S., OKA, S., & Gokoh, M. (2006) · Progress in Lipid Research · doi:10.1016/j.plipres.2006.03.003 · Cited by 356 · see citing works

Endocannabinoid Biosynthesis Proceeding through Glycerophospho-N-acyl Ethanolamine and a Role for α/β-Hydrolase 4 in This Pathway

Simon, G. M., & Cravatt, B. F. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m604660200 · Cited by 354 · see citing works

Inactivation of N-Acyl Phosphatidylethanolamine Phospholipase D Reveals Multiple Mechanisms for the Biosynthesis of Endocannabinoids

Leung, D., Saghatelian, A., Simon, G. M., & Cravatt, B. F. (2006) · Biochemistry · doi:10.1021/bi060163l · Cited by 348 · see citing works

In silico patent searching reveals a new cannabinoid receptor

Baker, D., Pryce, G., Davies, W. I. L., & Hiley, C. R. (2005) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2005.11.003 · Cited by 347 · see citing works

The CB1 receptor antagonist rimonabant reverses the diet‐induced obesity phenotype through the regulation of lipolysis and energy balance

Jbilo, O., Ravinet‐Trillou, C., Arnone, M., Buisson, I., Bribes, E., Péleraux, A., Pénarier, G., Soubrié, P., Fur, G. L., Galiègue, S., et al. (2005) · The FASEB Journal · doi:10.1096/fj.04-3177fje · Cited by 346 · see citing works

Molecular Characterization of N-Acylethanolamine-hydrolyzing Acid Amidase, a Novel Member of the Choloylglycine Hydrolase Family with Structural and Functional Similarity to Acid Ceramidase

Tsuboi, K., Sun, Y.-X., Okamoto, Y., Araki, N., Tonai, T., & Ueda, N. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m413473200 · Cited by 328 · see citing works

Oleoylethanolamide Stimulates Lipolysis by Activating the Nuclear Receptor Peroxisome Proliferator-activated Receptor α (PPAR-α)

Guzmán, M., Lo Verme, J., Fu, J., Oveisi, F., Blázquez, C., & Piomelli, D. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m404087200 · Cited by 328 · see citing works

Characterization of 1,2-diacylglycerol hydrolysis in human platelets. Demonstration of an arachidonoyl-monoacylglycerol intermediate.

Prescott, S. M., & Majerus, P. W. (1983) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)33114-4 · Cited by 315 · see citing works

Effects of the cannabinoid CB1 receptor antagonist SR141716 on oxygen consumption and soleus muscle glucose uptake in Lepob/Lepob mice

Liu, Y., Connoley, I. P., WILSON, C. A., & Stock, M. J. (2004) · International Journal of Obesity · doi:10.1038/sj.ijo.0802847 · Cited by 314 · see citing works

Phospholipase Cβ Serves as a Coincidence Detector through Its Ca2+ Dependency for Triggering Retrograde Endocannabinoid Signal

Hashimotodani, Y., Ohno‐Shosaku, T., Tsubokawa, H., Ogata, H., Emoto, K., Maejima, T., Araishi, K., Shin, H., & Kano, M. (2005) · Neuron · doi:10.1016/j.neuron.2005.01.004 · Cited by 314 · see citing works

Rimonabant reduces obesity-associated hepatic steatosis and features of metabolic syndrome in obese Zucker fa/fa rats

Gary‐Bobo, M., Elachouri, G., Gallas, J., Janiak, P., Marini, P., Ravinet‐Trillou, C., Chabbert, M., Cruccioli, N., Pfersdorff, C., Roque, C., et al. (2007) · Hepatology · doi:10.1002/hep.21641 · Cited by 304 · see citing works

Expression of Cannabinoid CB1 Receptors by Vagal Afferent Neurons Is Inhibited by Cholecystokinin

Burdyga, G., Lal, S., Varró, A., Dimaline, R., Thompson, D. G., & Dockray, G. J. (2004) · Journal of Neuroscience · doi:10.1523/jneurosci.5404-03.2004 · Cited by 279 · see citing works

Oleoylethanolamide, an endogenous PPAR-α agonist, lowers body weight and hyperlipidemia in obese rats

Fu, J., Oveisi, F., Gaetani, S., Lin, E., & Piomelli, D. (2005) · Neuropharmacology · doi:10.1016/j.neuropharm.2005.02.013 · Cited by 275 · see citing works

Cannabinoid receptors and endocannabinoids: Evidence for new players

Mackie, K., & Stella, N. (2006) · The AAPS Journal · doi:10.1007/bf02854900 · Cited by 275 · see citing works

Opposing Crosstalk between Leptin and Glucocorticoids Rapidly Modulates Synaptic Excitation via Endocannabinoid Release

Malcher‐Lopes, R., Di, S., Marcheselli, V., Weng, F., Stuart, C. T., Bazan, N. G., & Tasker, J. G. (2006) · Journal of Neuroscience · doi:10.1523/jneurosci.5126-05.2006 · Cited by 268 · see citing works

Activation of TRPV1 by the Satiety Factor Oleoylethanolamide

Ahern, G. P. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m305051200 · Cited by 256 · see citing works

Cannabinoid receptors regulate Ca2+ signals and insulin secretion in pancreatic β-cell

Juan-Picó, P., Fuentes, E., Bermúdez-Silva, F., Díaz-Molina, F. J., Ripoll, C., de Fonseca, F. D., & Nadal, A. (2006) · Cell Calcium · doi:10.1016/j.ceca.2005.10.005 · Cited by 251 · see citing works

Food Intake Regulates Oleoylethanolamide Formation and Degradation in the Proximal Small Intestine

Fu, J., Astarita, G., Gaetani, S., Kim, J., Cravatt, B. F., Mackie, K., & Piomelli, D. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m607809200 · Cited by 244 · see citing works

Biosynthesis of anandamide and N-palmitoylethanolamine by sequential actions of phospholipase A2 and lysophospholipase D

Yong-Xin, S. U. N., Tsuboi, K., Okamoto, Y., Tonai, T., Murakami, M., Kudo, I., & Ueda, N. (2004) · Biochemical Journal · doi:10.1042/bj20040031 · Cited by 236 · see citing works

Anandamide administration alone and after inhibition of fatty acid amide hydrolase (FAAH) increases dopamine levels in the nucleus accumbens shell in rats

Solinas, M., Justinová, Z., Goldberg, S. R., & Tanda, G. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.03880.x · Cited by 229 · see citing works

RNA Interference Suggests a Primary Role for Monoacylglycerol Lipase in the Degradation of the Endocannabinoid 2-Arachidonoylglycerol

Dinh, T. P., Kathuria, S., & Piomelli, D. (2004) · Molecular Pharmacology · doi:10.1124/mol.104.002071 · Cited by 227 · see citing works

Preferential effects of the cannabinoid CB1 receptor antagonist, SR 141716, on food intake and body weight gain of obese (fa/fa) compared to lean Zucker rats

Vickers, S. P., Webster, L. J., Wyatt, A. C., Dourish, C. T., & Kennett, G. A. (2003) · Psychopharmacology · doi:10.1007/s00213-002-1384-8 · Cited by 207 · see citing works

Presynaptic Monoacylglycerol Lipase Activity Determines Basal Endocannabinoid Tone and Terminates Retrograde Endocannabinoid Signaling in the Hippocampus

Hashimotodani, Y., Ohno‐Shosaku, T., & Kano, M. (2007) · Journal of Neuroscience · doi:10.1523/jneurosci.4159-06.2007 · Cited by 186 · see citing works

The cannabinoid CB1 receptor antagonist SR141716 blocks the orexigenic effects of intrahypothalamic ghrelin

Tucci, S. A., Rogers, E. K., Korbonits, M., & Kirkham, T. C. (2004) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705968 · Cited by 183 · see citing works

Ghrelin receptors in rat and human nodose ganglia: putative role in regulating CB-1 and MCH receptor abundance

Burdyga, G., Varró, A., Dimaline, R., Thompson, D. G., & Dockray, G. J. (2006) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00543.2005 · Cited by 182 · see citing works

Endogenous Unsaturated C18 N-Acylethanolamines Are Vanilloid Receptor (TRPV1) Agonists

Movahed, P., Jönsson, B., Birnir, B., Wingstrand, J. A., Dyhring, T., Ermund, A., Sterner, O., Zygmunt, P. M., & Högestätt, E. D. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m507429200 · Cited by 172 · see citing works

Regulation of food intake by oleoylethanolamide

Verme, J. L., Gaetani, S., Fu, J., Oveisi, F., Burton, K. J., & Piomelli, D. (2005) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-004-4494-0 · Cited by 169 · see citing works

Presence of the cannabinoid receptors, CB1 and CB2, in human omental and subcutaneous adipocytes

Roche, R., Hoareau, L., Bès-Houtmann, S., Gonthier, M., Laborde, C., Baron, J.-F., Haffaf, Y., Césari, M., & Festy, F. (2006) · Histochemistry and Cell Biology · doi:10.1007/s00418-005-0127-4 · Cited by 164 · see citing works

The Cannabinoid CB1 Receptor Antagonist Rimonabant (SR141716) Inhibits Cell Proliferation and Increases Markers of Adipocyte Maturation in Cultured Mouse 3T3 F442A Preadipocytes

Gary‐Bobo, M., Elachouri, G., Scatton, B., Fur, G. L., Oury-Donat, F., & Bensaïd, M. (2005) · Molecular Pharmacology · doi:10.1124/mol.105.015040 · Cited by 156 · see citing works

Discovery and Characterization of a Ca2+-independent Phosphatidylethanolamine N-Acyltransferase Generating the Anandamide Precursor and Its Congeners

Jin, X.-H., Okamoto, Y., Morishita, J., Tsuboi, K., Tonai, T., & Ueda, N. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m606369200 · Cited by 155 · see citing works

Cannabinoid Receptors and Endocannabinoids: Evidence for New Players

Mackie, K., & Stella, N. (2006) · The AAPS Journal · doi:10.1208/aapsj080234 · Cited by 149 · see citing works

The cannabinoid antagonist SR 141716A (Rimonabant) reduces the increase of extra-cellular dopamine release in the rat nucleus accumbens induced by a novel high palatable food

Melis, T., Succu, S., Sanna, F., Boi, A., Argiolas, A., & Melis, M. R. (2007) · Neuroscience Letters · doi:10.1016/j.neulet.2007.04.012 · Cited by 138 · see citing works

Effects of cannabinoid receptors on skeletal muscle oxidative pathways

Cavuoto, P., McAinch, A. J., Hatzinikolas, G., Cameron‐Smith, D., & Wittert, G. (2006) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2006.12.038 · Cited by 137 · see citing works

The Cannabinoid CB1 Receptor Antagonist Rimonabant (SR141716) Inhibits Human Breast Cancer Cell Proliferation through a Lipid Raft-Mediated Mechanism

Sarnataro, D., Pisanti, S., Santoro, A., Gazzerro, P., Malfitano, A. M., Laezza, C., & Bifulco, M. (2006) · Molecular Pharmacology · doi:10.1124/mol.106.025601 · Cited by 134 · see citing works

Down-regulation of cannabinoid-1 (CB-1) receptors in specific extrahypothalamic regions of rats with dietary obesity: a role for endogenous cannabinoids in driving appetite for palatable food?

Harrold, J. A., Elliott, J. C., King, P., Widdowson, P. S., & Williams, G. (2002) · Brain Research · doi:10.1016/s0006-8993(02)03245-6 · Cited by 130 · see citing works

Localization of CB 1 -cannabinoid receptor immunoreactivity in the porcine enteric nervous system

Kulkarni‐Narla, A., & Brown, D. R. (2000) · Cell and Tissue Research · doi:10.1007/s004410000261 · Cited by 126 · see citing works

Development of the first potent and specific inhibitors of endocannabinoid biosynthesis

Bisogno, T., Cascio, M. G., Saha, B., Mahadevan, A., Urbani, P., Minassi, A., Appendino, G., Saturnino, C., Martin, B. R., & Razdan, R. K. (2006) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2005.12.009 · Cited by 124 · see citing works

Role of cannabinoid CB2 receptors in glucose homeostasis in rats

Bermúdez‐Silva, F. J., Sánchez-Vera, I., Suárez, J., Serrano, A., Fuentes, E., Juan-Picó, P., Nadal, Á., & de Fonseca, F. R. (2007) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2007.02.066 · Cited by 120 · see citing works

Drug Treatment of the Overweight Patient

Bray, G. A., & Ryan, D. H. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.03.053 · Cited by 115 · see citing works

Antiobesity effects of the novel in vivo neutral cannabinoid receptor antagonist 5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-3-hexyl-1H-1,2,4-triazole – LH 21

Pavón, F. J., Bilbao, A., Hernández‐Folgado, L., Cippitelli, A., Jagerovic, N., Abellán, G., Rodrı́guez-Franco, M. I., Serrano, A., Macías, M., de Heras, R. G., et al. (2006) · Neuropharmacology · doi:10.1016/j.neuropharm.2006.03.029 · Cited by 113 · see citing works

Activation of cannabinoid CB1 receptors induces glucose intolerance in rats

Bermúdez‐Silva, F. J., Serrano, A., Diaz-Molina, F. J., Sánchez-Vera, I., Juan-Picó, P., Nadal, Á., Fuentes, E., & de Fonseca, F. R. (2006) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2005.12.016 · Cited by 109 · see citing works

Functional Analysis of the Purified Anandamide-generating Phospholipase D as a Member of the Metallo-β-lactamase Family

Wang, J., Okamoto, Y., Morishita, J., Tsuboi, K., Miyatake, A., & Ueda, N. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m512359200 · Cited by 106 · see citing works

Antiobesity Efficacy of a Novel Cannabinoid-1 Receptor Inverse Agonist, N-[(1 S,2 S)-3-(4-Chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl]-2-methyl-2-{[5-(trifluoromethyl)pyridin-2-yl]oxy}propanamide (MK-0364), in Rodents

Fong, T. M., Guan, X.-M., Marsh, D. J., Shen, C.-P., Stribling, D. S., Rosko, K., Lao, J. Z., Yu, H., Feng, Y., Xiao, J. C., et al. (2007) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.118737 · Cited by 104 · see citing works

Exercise reduces adipose tissue via cannabinoid receptor type 1 which is regulated by peroxisome proliferator-activated receptor-δ

Yan, Z. C., Liu, D. Y., Zhang, L. L., Shen, C., Li, Q., Cao, T. B., Wang, L., Nie, H., Zidek, W., Tepel, M., et al. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.12.213 · Cited by 104 · see citing works

Food intake is inhibited by oral oleoylethanolamide

Nielsen, M. J., Petersen, G. L., Astrup, A. V., & Hansen, H. S. (2004) · Journal of Lipid Research · doi:10.1194/jlr.c300008-jlr200 · Cited by 103 · see citing works

Evidence for an Interaction between CB1 Cannabinoid and Melanocortin MCR-4 Receptors in Regulating Food Intake

Verty, A. N. A., McFarlane, J. R., McGregor, I. S., & Mallet, P. E. (2004) · Endocrinology · doi:10.1210/en.2004-0059 · Cited by 100 · see citing works

Pharmacological Characterization of Hydrolysis-Resistant Analogs of Oleoylethanolamide with Potent Anorexiant Properties

Astarita, G., Giacomo, B. D., Gaetani, S., Oveisi, F., Compton, T. R., Rivara, S., Tarzia, G., Mor, M., & Piomelli, D. (2006) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.105221 · Cited by 91 · see citing works

Intestinal levels of anandamide and oleoylethanolamide in food-deprived rats are regulated through their precursors

Petersen, G. L., Sørensen, C., Schmid, P. C., Artmann, A., Tang‐Christensen, M., Hansen, S. H., Larsen, P. J., Schmid, H. H. O., & Hansen, H. S. (2006) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2005.12.011 · Cited by 90 · see citing works

Mechanism of oleoylethanolamide on fatty acid uptake in small intestine after food intake and body weight reduction

Yang, Y., Chen, M., Georgeson, K. E., & Harmon, C. M. (2006) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00270.2006 · Cited by 82 · see citing works

Predominant expression of lysosomal N-acylethanolamine-hydrolyzing acid amidase in macrophages revealed by immunochemical studies

Tsuboi, K., Zhao, L.-Y., Okamoto, Y., Araki, N., Ueno, M., Sakamoto, H., & Ueda, N. (2007) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2007.03.005 · Cited by 79 · see citing works

Cannabinoid-1 Receptor Antagonist, Rimonabant, for Management of Obesity and Related Risks

Gadde, K. M., & Allison, D. B. (2006) · Circulation · doi:10.1161/circulationaha.105.596130 · Cited by 76 · see citing works

Human adipose tissue binds and metabolizes the endocannabinoids anandamide and 2-arachidonoylglycerol

Spoto, B., Fezza, F., Parlongo, G., Battista, N., Sgro, E., Gasperi, V., Zoccali, C., & Maccarrone, M. (2006) · Biochimie · doi:10.1016/j.biochi.2006.07.019 · Cited by 75 · see citing works

Rimonabant: Just an Antiobesity Drug? Current Evidence on Its Pleiotropic Effects

Bifulco, M., Grimaldi, C., Gazzerro, P., Pisanti, S., & Santoro, A. (2007) · Molecular Pharmacology · doi:10.1124/mol.106.033118 · Cited by 74 · see citing works

Short-term exposure to alcohol in rats affects brain levels of anandamide, other N-acylethanolamines and 2-arachidonoyl-glycerol

Rubio, M., McHugh, D., Fernández‐Ruíz, J., Bradshaw, H. B., & Walker, J. M. (2007) · Neuroscience Letters · doi:10.1016/j.neulet.2007.05.052 · Cited by 74 · see citing works

Effect of the cannabinoid CB1receptor antagonist rimonabant on nociceptive responses and adjuvant‐induced arthritis in obese and lean rats

Croci, T., & Zarini, E. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707138 · Cited by 61 · see citing works

Oleylethanolamide impairs glucose tolerance and inhibits insulin-stimulated glucose uptake in rat adipocytes through p38 and JNK MAPK pathways

González-Yanes, C., Serrano, A., Bermúdez‐Silva, F. J., Hernández-Dominguez, M., Páez-Ochoa, M. A., de Fonseca, F. R., & Sánchez‐Margalet, V. (2005) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00555.2004 · Cited by 52 · see citing works

Endocannabinoid synthesis and degradation, and their regulation in the framework of energy balance.

Matias, I., & Marzo, V. D. (2006) · PubMed · Cited by 49 · see citing works

Endocannabinoid Blockade for Improving Glycemic Control and Lipids in Patients with Type 2 Diabetes Mellitus

Hollander, P. A. (2007) · The American Journal of Medicine · doi:10.1016/j.amjmed.2006.11.014 · Cited by 49 · see citing works

The cannabinoid receptor antagonist SR-141716A induces penile erection in male rats: Involvement of paraventricular glutamic acid and nitric oxide

Melis, M. R., Succu, S., Mascia, M. S., Sanna, F., Melis, T., Castelli, M. P., & Argiolas, A. (2005) · Neuropharmacology · doi:10.1016/j.neuropharm.2005.09.009 · Cited by 45 · see citing works

The cannabinoid CB1 receptor antagonist SR 141716A induces penile erection by increasing extra-cellular glutamic acid in the paraventricular nucleus of male rats

Succu, S., Mascia, M. S., Sanna, F., Melis, T., Argiolas, A., & Melis, M. R. (2006) · Behavioural Brain Research · doi:10.1016/j.bbr.2006.01.017 · Cited by 44 · see citing works

Suppression of food intake and food-reinforced behavior produced by the novel CB1 receptor antagonist/inverse agonist AM 1387

McLaughlin, P. J., Liu, Q., Wood, J. T., Wisniecki, A., Winston, K. M., Swezey, L. A., Ishiwari, K., Betz, A. J., Pandarinathan, L., Xu, W., et al. (2006) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2006.02.022 · Cited by 40 · see citing works

Oleylethanolamide Activates Ras-Erk Pathway and Improves Myocardial Function in Doxorubicin-Induced Heart Failure

Su, H., Samsamshariat, A., Fu, J., Shan, Y., Chen, Y., Piomelli, D., & Wang, P. H. (2005) · Endocrinology · doi:10.1210/en.2005-1098 · Cited by 39 · see citing works

The Endocannabinoid System: Mechanisms Behind Metabolic Homeostasis and Imbalance

Woods, S. C. (2007) · The American Journal of Medicine · doi:10.1016/j.amjmed.2006.11.013 · Cited by 34 · see citing works

Cold Exposure Stimulates Synthesis of the Bioactive Lipid Oleoylethanolamide in Rat Adipose Tissue

LoVerme, J., Guzmán, M., Gaetani, S., & Piomelli, D. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m604751200 · Cited by 31 · see citing works

Signalling cognition: The gut microbiota and hypothalamic-pituitary-adrenal axis

Rusch, J. A., Layden, B. T., & Dugas, L. R. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1130689 · Cited by 415 · see citing works

Cannabinoid receptor antagonists: pharmacological opportunities, clinical experience, and translational prognosis

Janero, D. R., & Makriyannis, A. (2009) · Expert Opinion on Emerging Drugs · doi:10.1517/14728210902736568 · Cited by 186 · see citing works

Biology of endocannabinoid synthesis system

Wang, J., & Ueda, N. (2008) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2008.12.002 · Cited by 182 · see citing works

Lipotoxicity: Why do saturated fatty acids cause and monounsaturates protect against it?

Nolan, C. J., & Larter, C. Z. (2009) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2009.05823.x · Cited by 132 · see citing works

Expression and Secretion of N-acylethanolamine-hydrolysing Acid Amidase in Human Prostate Cancer Cells

Wang, J., Zhao, L.-Y., Uyama, T., Tsuboi, K., Wu, X., Kakehi, Y., & Ueda, N. (2008) · The Journal of Biochemistry · doi:10.1093/jb/mvn122 · Cited by 44 · see citing works

Hyperactivity induced by the dopamine D2/D3 receptor agonist quinpirole is attenuated by inhibitors of endocannabinoid degradation in mice

Rojas, M. J. L., Galeano, P., Suárez, J., Araos, P. F., Santín, L. J., de Fonseca, F. R., & Blanco, E. (2012) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145712000569 · Cited by 38 · see citing works

The endocannabinoid 2-arachidonoylglycerol mediates D1 and D2 receptor cooperative enhancement of rat nucleus accumbens core neuron firing

Seif, T., Makriyannis, A., Kunos, G., Bonci, A., & Hopf, F. W. (2011) · Neuroscience · doi:10.1016/j.neuroscience.2011.07.055 · Cited by 37 · see citing works

The Endocannabinoid System and Sex Steroid Hormone-Dependent Cancers

Ayakannu, T., Taylor, A. H., Marczylo, T. H., Willets, J. M., & Konje, J. C. (2013) · International Journal of Endocrinology · doi:10.1155/2013/259676 · Cited by 32 · see citing works

Cannabinoid receptor-dependent metabolism of 2-arachidonoylglycerol during aging

Pascual, A. C., Gaveglio, V. L., Giusto, N. M., & Pasquaré, S. J. (2014) · Experimental Gerontology · doi:10.1016/j.exger.2014.04.008 · Cited by 20 · see citing works

Mechanisms of N-oleoyldopamine activation of central histaminergic neurons

Luca, R. D., Mazur, K., Kernder, A. L., Suvorava, T., Kojda, G., Haas, H. L., & Sergeeva, O. A. (2018) · Neuropharmacology · doi:10.1016/j.neuropharm.2018.09.006 · Cited by 17 · see citing works

A second‐order schedule of food reinforcement in rats to examine the role of CB1 receptors in the reinforcement‐enhancing effects of nicotine

Wing, V. C., & Shoaib, M. C. (2010) · Addiction Biology · doi:10.1111/j.1369-1600.2009.00203.x · Cited by 15 · see citing works

Protein purification and cloning of diacylglycerol lipase from rat brain

Aso, C., Araki, M., Ohshima, N., Tatei, K., Hirano, T., Obinata, H., Kishi, M., Kishimoto, K., Konishi, A., Goto, F., et al. (2016) · The Journal of Biochemistry · doi:10.1093/jb/mvw002 · Cited by 10 · see citing works

The GABAergic System and Endocannabinoids in Epilepsy and Seizures: What Can We Expect from Plant Oils?

de Oliveira, F. R., da Silva, N. M., Hamoy, M., Lopez, M. E. C., Ferreira, I. M., da Silva, E. O., Macchi, B. D. M., & do Nascimento, J. L. M. (2022) · Molecules · doi:10.3390/molecules27113595 · Cited by 6 · see citing works

Role of Endocannabinoid System Perturbation in Organophosphate‐Mediated Metabolic Impairment and Neuroinflammation

Arida, R. E., El-Gameel, D., Bassiouni, W., Sandilya, V., Abdallah, S. M., Mechref, Y. S., Abd‐Elrahman, K. S., & EL‐Yazbi, A. F. (2026) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/bcpt.70198 · Cited by 2 · see citing works

Neurobiology of Substance Abuse

Bedendo, A., Andrade, A. L. M., & Noto, A. R. (2016) · Springer eBooks · doi:10.1007/978-3-319-43172-7_2 · Cited by 2 · see citing works

Protective Effects of Oleoylethanolamine on Diabetic Nephropathy: Role of AMP-Activated Protein Kinase/Nuclear Factor-E2-Related Factor 2 Pathway

Wu, Y., Li, S., Liu, Y., Yang, L., & Lin, W. (2023) · Science of Advanced Materials · doi:10.1166/sam.2023.4460

12 Niet-alcoholische steatohepatitis

Jansen, P. L. M. (2009) · Bohn Stafleu van Loghum eBooks · doi:10.1007/978-90-313-7437-3_12

The endocannabinoid system: Body weight and metabolic regulation

Engeli, S., & Jordan, J. (2006) · Clinical cornerstone · doi:10.1016/s1098-3597(06)80041-4 · Cited by 30 · see citing works

Reducing cardiometabolic risk through selective antagonism of CB1 receptors

Gaal, L. V. (2007) · Clinical cornerstone · doi:10.1016/s1098-3597(07)80012-3 · Cited by 2 · see citing works

Endocannabinoid system in food intake and metabolic regulation

Jesudason, D. R., & Wittert, G. (2008) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e328304b62b · Cited by 43 · see citing works

The Endocannabinoid System as a Target for the Treatment of Visceral Obesity and Metabolic Syndrome

Kyrou, I., Valsamakis, G., & Tsigos, C. (2006) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1367.024 · Cited by 35 · see citing works

The Endocannabinoid System in the Physiopathology of Metabolic Disorders

Pagotto, U., Vicennati, V., & Pasquali, R. (2007) · Hormone Research in Paediatrics · doi:10.1159/000097580 · Cited by 8 · see citing works